Patents by Inventor Ammar M. Killu

Ammar M. Killu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220296881
    Abstract: The present disclosure relates generally to electroporation systems and utilizing algorithms for electroporation pulse delivery including a patient's EKG/EGM monitoring. In some embodiments, an electroporation delivery system may include an electrocardiogram operatively connected to a processing device and a memory. One or more sensors may be operatively connected to the electrocardiogram for measuring electrical activity QRS complex of a patient's heart. One or more electrodes for treatment may be disposed in, at, or near the patient's heart, the one or more electrodes operatively connected to a pulse delivery mechanism. The electroporation delivery system may be configured to determine whether an electroporation pulse is deliverable to a patient based on the electrocardiogram.
    Type: Application
    Filed: June 6, 2022
    Publication date: September 22, 2022
    Inventors: Samuel J. Asirvatham, Suraj Kapa, Sarah M. Gruba, Douglas D. Pagoria, James P. Rohl, Chance M. Witt, Ammar M. Killu, Niyada Naksuk
  • Patent number: 11389642
    Abstract: The present disclosure relates generally to electroporation systems and utilizing algorithms for electroporation pulse delivery including a patient's EKG/EGM monitoring. In some embodiments, an electroporation delivery system may include an electrocardiogram operatively connected to a processing device and a memory. One or more sensors may be operatively connected to the electrocardiogram for measuring electrical activity QRS complex of a patient's heart. One or more electrodes for treatment may be disposed in, at, or near the patient's heart, the one or more electrodes operatively connected to a pulse delivery mechanism. The electroporation delivery system may be configured to determine whether an electroporation pulse is deliverable to a patient based on the electrocardiogram.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: July 19, 2022
    Assignees: Cardiac Pacemakers, Inc., Mayo Foundation for Medical Education and Research
    Inventors: Samuel J. Asirvatham, Suraj Kapa, Sarah M. Gruba, Douglas D. Pagoria, James P. Rohl, Chance M. Witt, Ammar M. Killu, Niyada Naksuk
  • Publication number: 20190060632
    Abstract: The present disclosure relates generally to electroporation systems and utilizing algorithms for electroporation pulse delivery including a patient's EKG/EGM monitoring. In some embodiments, an electroporation delivery system may include an electrocardiogram operatively connected to a processing device and a memory. One or more sensors may be operatively connected to the electrocardiogram for measuring electrical activity QRS complex of a patient's heart. One or more electrodes for treatment may be disposed in, at, or near the patient's heart, the one or more electrodes operatively connected to a pulse delivery mechanism. The electroporation delivery system may be configured to determine whether an electroporation pulse is deliverable to a patient based on the electrocardiogram.
    Type: Application
    Filed: August 21, 2018
    Publication date: February 28, 2019
    Inventors: Samuel J. Asirvatham, Suraj Kapa, Sarah M. Gruba, Douglas D. Pagoria, James P. Rohl, Chance M. Witt, Ammar M. Killu, Niyada Naksuk
  • Publication number: 20180318003
    Abstract: Devices and methods can be used to treat heart conditions such as hypertrophic cardiomyopathy (HCM). For example, this document describes transcatheter myocardial volume reduction devices and methods for treating HCM. In some implementations described in this document, a transcatheter irreversible electroporation (IRE) technique is used to treat HCM. In some cases, such a technique is used to deliver non-thermal ablation to myocardial cellular components such as the ventricular septum. The bulk of the ventricular septum's myocardial tissue can be reduced in result.
    Type: Application
    Filed: May 1, 2018
    Publication date: November 8, 2018
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Ammar M. Killu, Elad Maor, Rick A. Nishimura, Samuel J. Asirvatham, Amir Lerman